Researchers have identified a biomarker that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy to prevent a disease recurrence.
Tom Maniatis discusses the potential of precision medicine and how success will depend on Columbia’s commitment to building and enhancing multiple disciplines related to the field.
The latest gift from dedicated philanthropists Florence and Herbert Irving will benefit precision medicine, cancer, and faculty development.
In Columbia's biomedical engineering department, engineers and physicians work together to solve problems and improve health care.
A new prenatal DNA test detects more cases of Down syndrome than standard screening, a study by Columbia and UCSF researchers has found.
At Columbia, every pediatric cancer patient’s tumor is sequenced, so personalized treatment may be considered.